This is the protocol for a review and there is no abstract. The objectives are as follows:, I. To determine the effect of first-line methyldopa (as either monotherapy or in combination therapy) as compared with placebo and other first-line antihypertensives in adults with primary hypertension on:, (a) Mortality, (b) Morbidity, (c) Withdrawals due to adverse events., (d) Systolic and diastolic blood pressure